Stay updated on Olaparib Plus Pembrolizumab Clinical Trial
Sign up to get notified when there's something new on the Olaparib Plus Pembrolizumab Clinical Trial page.

Latest updates to the Olaparib Plus Pembrolizumab Clinical Trial page
- Check5 days agoNo Change Detected
- Check12 days agoChange DetectedAdded Revision: v3.3.3; removed HHS Vulnerability Disclosure and Revision: v3.3.2.SummaryDifference0.1%

- Check19 days agoNo Change Detected
- Check26 days agoNo Change Detected
- Check41 days agoChange DetectedRevision: v3.3.2 was added to the page. Revision: v3.2.0 was removed.SummaryDifference0.0%

- Check48 days agoChange DetectedRemoved a general site-wide notice about government funding and the NIH Clinical Center's operating status; this deletion does not affect trial information or data. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.2%

- Check62 days agoChange DetectedThe Record History now includes a new version entry (Version 147, submitted 2025-03-14) to the study's history.SummaryDifference0.0%

- Check91 days agoChange DetectedMajor update: announces a version upgrade to v3.2.0 and publicly states funding-related operational notices, including that transactions may not be processed until appropriations are enacted.SummaryDifference6%

- Check98 days agoChange DetectedThe page now reflects the new version revision v3.1.0, replacing the old v3.0.2.SummaryDifference0.1%

Stay in the know with updates to Olaparib Plus Pembrolizumab Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Olaparib Plus Pembrolizumab Clinical Trial page.